Training on Using ıInsulin in Patients With Type 2 Diabetes

Completed

• Conditions: Insulin Dependent Diabetes; Diabetes type2

• Registration Number: NCT05915338
• Lead Sponsor: Inonu University

Brief Summary

This study was conducted to evaluate the effect of individual insulin use training given to patients with type 2 diabetes using insulin on safe drug administration, pain level and perception of treatment. The study was conducted between October 2022 and March 2023 with a randomized control group.

Detailed Description

Objective: The aim of this study was to examine the effects of individual insulin use training given to patients with Type 2 diabetes on safe drug administration, pain level and treatment perception, and to contribute to both national and international literature.

Method: It was conducted between October 2022 and March 2023 as a randomized controlled study in a pre-test-post-test order to determine the effect of individual insulin use education given to patients with type 2 diabetes on safe drug administration, pain level and treatment perception. The data were collected by the researchers with the descriptive information form of the patients, the Insulin Administration Skill Observation Form, the Visual Analogue Scale and the Insulin Therapy Evaluation Scale.

Data Collection: Face-to-face and individual interviews with patients who applied to the Internal Diseases and Endocrinology Polyclinic and Diabetes Nursing Polyclinics of a state hospital in a city located in the Southeastern Anatolia Region of Turkey, and who were hospitalized in the Internal Diseases, Endocrinology, Physical Therapy and Rehabilitation and Cardiology Services. collected using the method. A pilot study was not conducted before starting the study. Before the study, all patients were informed about the study and their verbal and written consents were obtained.

Study Timeline

• Study Start: 2022-10-01
• Primary Completion: 2023-01-05
• Study Completion: 2023-03-30
• Status Verified: 2023-06
• Study First Submitted: 2023-06-09
• Study First Submitted QC: 2023-06-21
• Last Update Submitted: 2023-06-22
• Study First Posted: 2023-06-23
• Last Update Posted: 2023-06-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 84

Inclusion Criteria

Patients included in the study;

• 18 years and over Using insulin injections for at least six months or longer
• Meeting the American Diabetes Association (ADA, 2021) diagnostic criteria for Type 2 diabetes
• No communication and mental problems
• Insulin injection made by himself or his family The patients who agreed to participate in the study.

Exclusion Criteria

Patients excluded from the study;

• Self or family member health personnel Those with advanced retinopathy, nephropathy, neuropathy
• Diagnosed with type 1 diabetes
• Pregnant or breastfeeding women
• Patients who participated in another clinical trial concurrently or within 1 month prior to the start of the trial.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fırst follow - up survey	Fırst test-fırst applıcatıon both groups at the begınnıng of the research	Pretest data was obtained using the introductory information form, IASOF, VAS, and ITES.; Patients were requested to apply their daily dose of insulin to themselves and patients' application skills were recorded by the researchers into IASOF as the 1st observation.

Secondary Outcome Measures

Name	Time	Method
Last test survey	2 weeks after the fırst watch	Posttest data was obtained through the use of IASOF, VAS, and ITES. Patients were requested to apply their insulin dose of the day to themselves. Patients' insulin application skills were recorded by researchers into IASOF as the 2nd observation.

Trial Locations

Locations (1)

Şirnak Devlet Hastanesi; 🇹🇷 Şirnak, Merkez, Turkey